Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension. En savoir plus sur Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.
How can we minimise the use of regular oral corticosteroids in asthma? En savoir plus sur How can we minimise the use of regular oral corticosteroids in asthma?
Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma. En savoir plus sur Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma.
Gas Exchange and Ventilatory Efficiency During Exercise in Pulmonary Vascular Diseases. En savoir plus sur Gas Exchange and Ventilatory Efficiency During Exercise in Pulmonary Vascular Diseases.
Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme. En savoir plus sur Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme.
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohort. En savoir plus sur Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohort.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD. En savoir plus sur Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.